CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,000 | +115.5% | 952,343 | +208.4% | 0.03% | +22.2% |
| Q4 2022 | $1,856 | -99.5% | 308,813 | +281.6% | 0.03% | +440.0% |
| Q1 2022 | $378,000 | -31.4% | 80,916 | -57.3% | 0.01% | -37.5% |
| Q1 2021 | $551,000 | -27.4% | 189,516 | -19.6% | 0.01% | +14.3% |
| Q4 2020 | $759,000 | – | 235,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
| Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
| Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
| NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
| BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
| Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
| EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
| Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
| Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |